IHS Chemical Week

Regions :: North America :: U.S.

Amneal and Intrexon collaborate for API production

12:15 PM MDT | March 10, 2014 | Deepti Ramesh

Generic drug manufacturer Amneal Pharmaceuticals (Bridgewater, NJ) and biotech company Intrexon (Germantown, MD) say that they have entered into a collaboration to develop an improved production process for a complex active pharmaceutical ingredient (API). The vast majority of APIs are currently produced through a series of complex chemical processes. The goal of the collaboration is to develop a biological process for a targeted API product that may reduce the cost of production. The collaboration will leverage Intrexon's proprietary UltraVector platform as well...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa